← Eichor
Condition: Multiple Chronic Illnesses Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Multiple Chronic Illnesses

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
NA · 2 location(s) · Brigham and Women's Hospital · NCT05282654Bringing the Outdoors In: Virtual Nature Walks for Depression in Multiple Sclerosis (MS) Patients
NA · 1 location(s) · University of Michigan · NCT07392879Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
NA · 1 location(s) · Cionic, Inc. · NCT05964829A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcuta
Phase 1 · 12 location(s) · Hoffmann-La Roche · NCT07667322China National Registry of Neuro-Inflammatory Diseases
Phase N/A · 1 location(s) · Beijing Tiantan Hospital · NCT05154370A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics for a Single Dose of HRS-9821 Powder
Phase 1 · 1 location(s) · Guangdong Hengrui Pharmaceutical Co., Ltd · NCT07116915Multi-parametric MRI Evaluation of Renal Graft Performance After Living Donor Donation.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06047106Precision Medicine and Physical Function
NA · 1 location(s) · University of North Carolina, Chapel Hill · NCT05877846Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-
Phase 1 · 8 location(s) · Newave Pharmaceutical Inc · NCT04771572Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC)
NA · 5 location(s) · Zealand University Hospital · NCT07460999A Real World, Multi-centric, Observational Registry Study of Chronic Kidney Diseases
Phase N/A · 8 location(s) · Guangdong Provincial People's Hospital · NCT05188885Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Phase 2 · 5 location(s) · Hansa Biopharma AB · NCT05753930A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
Phase 3 · 40 location(s) · Zenas BioPharma (USA), LLC · NCT07067463Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis
Phase N/A · 1 location(s) · Shirley Ryan AbilityLab · NCT06516458Lung Health of Early COPD: A Multi-center Cohort Study
Phase N/A · 2 location(s) · Ting YANG · NCT05466396Assessment and Management of Multiple Drug Use in Elderly Chronic Disease Patients
Phase N/A · 1 location(s) · Xijing Hospital · NCT07180368Effects of Transcranial Static Magnetic Field Stimulation (tSMS) in Progressive Multiple Sclerosis
NA · 1 location(s) · Neuromed IRCCS · NCT05811013Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients W
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06904066A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urt
Phase 3 · 73 location(s) · Celldex Therapeutics · NCT07266402A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
NA · 3 location(s) · Pulmair Medical, Inc. · NCT07119229A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Fo
Phase 1 · 1 location(s) · Stanford University · NCT06138132Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
Phase 3 · 22 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04047628A Multi-center RCT to Evaluate Subsegmental BTVA Treatment for Severe Emphysema
NA · 9 location(s) · Shanghai Chest Hospital · NCT06152107Deep Phenotyping of CIndU
Phase N/A · 3 location(s) · Centre for Human Drug Research, Netherlands · NCT07359430Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Phase N/A · 7 location(s) · Dana-Farber Cancer Institute · NCT02269592Adult Disease Risk Prediction Using Wearables, Hearing, and Health Data
Phase N/A · 1 location(s) · National Health Research Institutes, Taiwan · NCT07541547A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · 921 location(s) · AstraZeneca · NCT06283966Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study
Phase N/A · 1 location(s) · Rigshospitalet, Denmark · NCT06040567
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.